Position in GRFS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,863,760
-$380,217 QoQ
Shares Held
404,486
0.0% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#32
of 164 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 86%
Shared 0%
None 14%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CAPITAL INTERNATIONAL LTD /CA/ holds $216,358,127 across 7 Drug Manufacturers - General names. GRFS ranks #7 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
506,085 | $95,963,837 | |
| 2 | LLY |
ELI LILLY & Co
|
71,334 | $85,560,146 | |
| 3 | ABBV |
AbbVie Inc.
|
44,477 | $11,192,192 | |
| 4 | PFE |
Pfizer Inc
|
439,717 | $10,588,385 | |
| 5 | AMGN |
Amgen Inc
|
19,011 | $6,884,263 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
57,368 | $3,305,544 | |
| 7 | GRFS |
Grifols SA
This page
|
404,486 | $2,863,760 |
All Filings in GRFS
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,863,760 | 404,486 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $3,243,977 | 404,486 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,781,944 | 404,486 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,028,680 | 404,486 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,656,553 | 404,486 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $2,875,895 | 404,486 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $3,009,375 | 404,486 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $3,624,016 | 408,110 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $2,575,174 | 408,110 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,726,174 | 408,110 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,497,556 | 389,062 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $3,588,482 | 392,613 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $3,596,335 | 392,613 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,893,557 | 392,613 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $3,217,258 | 378,501 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,002,831 | 325,135 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,150,172 | 265,166 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,372,441 | 203,120 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $2,776,100 | 247,204 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,651,185 | 249,910 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,375,236 | 252,175 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,938,904 | 227,814 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $3,916,324 | 212,382 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,412,259 | 196,672 | Shares | Defined | 2020-11-13 | |
| No filing history on record for this holder in this stock. | ||||||